Back

Fagron NV

Below you will find information from the register publication of inside information. The information has been provided by the organisation.

  • Registration date 16 feb 2011 - 07:40
  • Statutory name Fagron NV
  • Title REBITDA, EBIT and recurrent net profit increase double digit and faster than turnover
  • Comments Strong performance by Fagron, Arseus Medical & Corilus Key points 2010: Turnover growth of 8.4% to EUR 424.1 million REBITDA increases 14.7% to EUR 60.4 million EBIT increases 17.9% to EUR 36.0 million Recurrent net profit per share increases 21.0% to EUR 0.98 Dividend proposal 2010: EUR 0.44 per share, 22% higher than in 2009 Outlook for 2011: Turnover growth of between 8% and 12%, organic turnover growth of between 3% and 6% and a REBITDA that is expected to grow faster than turnover

Related downloads

201102160000000009_Arseus_eng.pdf
201102160000000009_Arseus_nl.pdf

Date last update: 23 September 2021

Share information

Share on: Share this